Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light.
暂无分享,去创建一个
Qidong You | Q. You | Zhihong Li | Kaijun Su | Zhensheng Jiang | Yancheng Yu | Xiaojin Zhang | Xiaojin Zhang | Zhihong Li | Zhensheng Jiang | Kaijun Su | Yancheng Yu
[1] U. Holzgrabe,et al. Fluorination of Photoswitchable Muscarinic Agonists Tunes Receptor Pharmacology and Photochromic Properties. , 2019, Journal of medicinal chemistry.
[2] Q. You,et al. Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors. , 2015, ACS medicinal chemistry letters.
[3] A. Massaguer,et al. A Green Light-Triggerable RGD Peptide for Photocontrolled Targeted Drug Delivery: Synthesis and Photolysis Studies. , 2016, The Journal of organic chemistry.
[4] J. O'connor,et al. Prolyl hydroxylase domain inhibitors: can multiple mechanisms be an opportunity for ischemic stroke? , 2019, Neuropharmacology.
[5] G. Semenza,et al. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.
[6] H. Eichler,et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. , 2000, Blood.
[7] J. Zondlo,et al. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] Mukul R Jain,et al. Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases. , 2018, Journal of medicinal chemistry.
[9] Gooitzen M van Dam,et al. Emerging Targets in Photopharmacology. , 2016, Angewandte Chemie.
[10] M. Famulok,et al. Temporal and Reversible Control of a DNAzyme by Orthogonal Photoswitching. , 2018, Journal of the American Chemical Society.
[11] Wiktor Szymanski,et al. Photoactivation of MDM2 Inhibitors: Controlling Protein–Protein Interaction with Light , 2018, Journal of the American Chemical Society.
[12] P. Toselli,et al. Hypoxia-response element (HRE)-directed transcriptional regulation of the rat lysyl oxidase gene in response to cobalt and cadmium. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[13] D. Trauner,et al. A roadmap to success in photopharmacology. , 2015, Accounts of Chemical Research.
[14] P. Ratcliffe,et al. Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases. , 2013, ACS chemical biology.
[15] Jing Gu,et al. Click Chemistry-Based Discovery of [3-Hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia. , 2018, Journal of medicinal chemistry.
[16] B. Feringa,et al. Orthogonal control of antibacterial activity with light. , 2014, ACS chemical biology.
[17] S. Walmsley,et al. Inflammation and Hypoxia: HIF and PHD Isoform Selectivity. , 2019, Trends in molecular medicine.
[18] M. Ivan,et al. Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.
[19] J. Hale,et al. Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia , 2010, Expert opinion on therapeutic patents.
[20] Verónica San Miguel,et al. Wavelength-selective caged surfaces: how many functional levels are possible? , 2011, Journal of the American Chemical Society.
[21] R. Givens,et al. Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy , 2012, Chemical reviews.
[22] Ting-Ting Wu,et al. Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function , 2018, Front. Aging Neurosci..
[23] M. Weiss,et al. Anemia: progress in molecular mechanisms and therapies , 2015, Nature Medicine.